ADUS
ADUS
Addus HomeCare CorporationIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $373.08M ▲ | $81.33M ▼ | $29.78M ▲ | 7.98% ▲ | $1.61 ▲ | $46.42M ▲ |
| Q3-2025 | $362.3M ▲ | $83.78M ▲ | $22.85M ▲ | 6.31% ▼ | $1.22 | $37.34M ▼ |
| Q2-2025 | $349.44M ▲ | $80.99M ▲ | $22.05M ▲ | 6.31% ▲ | $1.22 ▲ | $37.38M ▲ |
| Q1-2025 | $337.71M ▲ | $77.16M ▲ | $21.23M ▲ | 6.29% ▼ | $1.18 ▲ | $34.96M ▲ |
| Q4-2024 | $297.14M | $74.57M | $19.53M | 6.57% | $1.08 | $31.71M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $81.62M ▼ | $1.44B ▲ | $352M ▼ | $1.09B ▲ |
| Q3-2025 | $101.92M ▲ | $1.42B ▲ | $372.96M ▼ | $1.05B ▲ |
| Q2-2025 | $91.18M ▼ | $1.41B ▲ | $387.08M ▼ | $1.02B ▲ |
| Q1-2025 | $96.95M ▼ | $1.41B ▼ | $412.2M ▼ | $995.38M ▲ |
| Q4-2024 | $98.91M | $1.41B | $442.14M | $970.49M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $29.78M ▲ | $18.76M ▼ | $-10.06M ▲ | $-29.01M ▼ | $-20.3M ▼ | $0 ▼ |
| Q3-2025 | $22.85M ▲ | $51.29M ▲ | $-22.76M ▼ | $-17.79M ▲ | $10.74M ▲ | $49.37M ▲ |
| Q2-2025 | $-21.23M ▼ | $22.53M ▲ | $1.7M ▲ | $-30M ▼ | $-5.78M ▼ | $24.41M ▲ |
| Q1-2025 | $21.23M ▲ | $18.95M ▲ | $-1.38M ▲ | $-19.53M ▼ | $-1.96M ▲ | $17.07M ▲ |
| Q4-2024 | $19.53M | $10.42M | $-354.49M | $220.13M | $-123.94M | $8.72M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Home Health | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Hospice | $60.00M ▲ | $60.00M ▲ | $70.00M ▲ | $70.00M ▲ |
Personal Care | $260.00M ▲ | $270.00M ▲ | $280.00M ▲ | $290.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Addus HomeCare Corporation's financial evolution and strategic trajectory over the past five years.
Addus combines solid profitability and strong cash generation with a conservative balance sheet featuring low leverage and ample liquidity. It operates in a growing segment of healthcare, supported by aging demographics and a policy preference for home- and community-based care. Competitive strengths include scale, a broad continuum of services, a focus on government-funded programs, and a capital-light model enhanced by integrated technology platforms and disciplined acquisitions.
Main risks center on its operating environment: heavy dependence on Medicaid and other public or managed-care reimbursement, persistent caregiver shortages and wage pressure, and ongoing regulatory and policy changes. The balance sheet’s concentration in goodwill and intangibles highlights exposure to acquisition underperformance. Limited multi-year visibility in the provided data makes it harder to assess the durability of growth and margins, and any missteps in integrating acquisitions or rolling out technology could erode some of its current advantages.
Looking forward, the structural demand for home-based care and the shift toward value-based arrangements give Addus a favorable backdrop. Its financial strength and technology-enabled, integrated care model provide tools to pursue further growth, particularly through targeted acquisitions and deeper payer partnerships. Actual outcomes will depend on management’s ability to maintain margins amid labor and reimbursement pressures, successfully integrate acquired operations into its technology platform, and continue demonstrating cost savings and quality improvements to key payers.
About Addus HomeCare Corporation
https://addus.comAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $373.08M ▲ | $81.33M ▼ | $29.78M ▲ | 7.98% ▲ | $1.61 ▲ | $46.42M ▲ |
| Q3-2025 | $362.3M ▲ | $83.78M ▲ | $22.85M ▲ | 6.31% ▼ | $1.22 | $37.34M ▼ |
| Q2-2025 | $349.44M ▲ | $80.99M ▲ | $22.05M ▲ | 6.31% ▲ | $1.22 ▲ | $37.38M ▲ |
| Q1-2025 | $337.71M ▲ | $77.16M ▲ | $21.23M ▲ | 6.29% ▼ | $1.18 ▲ | $34.96M ▲ |
| Q4-2024 | $297.14M | $74.57M | $19.53M | 6.57% | $1.08 | $31.71M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $81.62M ▼ | $1.44B ▲ | $352M ▼ | $1.09B ▲ |
| Q3-2025 | $101.92M ▲ | $1.42B ▲ | $372.96M ▼ | $1.05B ▲ |
| Q2-2025 | $91.18M ▼ | $1.41B ▲ | $387.08M ▼ | $1.02B ▲ |
| Q1-2025 | $96.95M ▼ | $1.41B ▼ | $412.2M ▼ | $995.38M ▲ |
| Q4-2024 | $98.91M | $1.41B | $442.14M | $970.49M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $29.78M ▲ | $18.76M ▼ | $-10.06M ▲ | $-29.01M ▼ | $-20.3M ▼ | $0 ▼ |
| Q3-2025 | $22.85M ▲ | $51.29M ▲ | $-22.76M ▼ | $-17.79M ▲ | $10.74M ▲ | $49.37M ▲ |
| Q2-2025 | $-21.23M ▼ | $22.53M ▲ | $1.7M ▲ | $-30M ▼ | $-5.78M ▼ | $24.41M ▲ |
| Q1-2025 | $21.23M ▲ | $18.95M ▲ | $-1.38M ▲ | $-19.53M ▼ | $-1.96M ▲ | $17.07M ▲ |
| Q4-2024 | $19.53M | $10.42M | $-354.49M | $220.13M | $-123.94M | $8.72M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Home Health | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Hospice | $60.00M ▲ | $60.00M ▲ | $70.00M ▲ | $70.00M ▲ |
Personal Care | $260.00M ▲ | $270.00M ▲ | $280.00M ▲ | $290.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Addus HomeCare Corporation's financial evolution and strategic trajectory over the past five years.
Addus combines solid profitability and strong cash generation with a conservative balance sheet featuring low leverage and ample liquidity. It operates in a growing segment of healthcare, supported by aging demographics and a policy preference for home- and community-based care. Competitive strengths include scale, a broad continuum of services, a focus on government-funded programs, and a capital-light model enhanced by integrated technology platforms and disciplined acquisitions.
Main risks center on its operating environment: heavy dependence on Medicaid and other public or managed-care reimbursement, persistent caregiver shortages and wage pressure, and ongoing regulatory and policy changes. The balance sheet’s concentration in goodwill and intangibles highlights exposure to acquisition underperformance. Limited multi-year visibility in the provided data makes it harder to assess the durability of growth and margins, and any missteps in integrating acquisitions or rolling out technology could erode some of its current advantages.
Looking forward, the structural demand for home-based care and the shift toward value-based arrangements give Addus a favorable backdrop. Its financial strength and technology-enabled, integrated care model provide tools to pursue further growth, particularly through targeted acquisitions and deeper payer partnerships. Actual outcomes will depend on management’s ability to maintain margins amid labor and reimbursement pressures, successfully integrate acquired operations into its technology platform, and continue demonstrating cost savings and quality improvements to key payers.

CEO
R. Dirk Allison CPA
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
XSMC.TO
Weight:0.12%
Shares:1.11M
IJR.AX
Weight:0.12%
Shares:1.11M
VTS.AX
Weight:0.00%
Shares:585.43K
Summary
Showing Top 3 of 168
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Stephens & Co.
Overweight
Barclays
Underweight
RBC Capital
Outperform
TD Cowen
Buy
JMP Securities
Market Outperform
Macquarie
Outperform
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
EOS PARTNERS, L.P.
Shares:4.02M
Value:$416.5M
BLACKROCK INC.
Shares:2.87M
Value:$297.3M
BLACKROCK, INC.
Shares:2.81M
Value:$290.82M
Summary
Showing Top 3 of 405

